Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: Case reports

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3547-3551

  Kawaguchi, Makiko ^a   Banno, Kouji ^a   Susumu, Nobuyuki ^a   Yanokura, Megumi ^a   Kuwabara, Yoshiko ^a   Hirao, Nobumaru ^a   Tsukazaki, Katsumi ^a   Nozawa, Shiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ascitic fluid; Collagen gel droplet embedded culture drug sensitivity test (CD DST); Neoadjuvant chemotherapy; Ovarian cancer; Pleural fluid

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; IRINOTECAN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER REGRESSION; CASE REPORT; COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST; DRUG SENSITIVITY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY CANCER; PLEURA FLUID; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCITES; CAMPTOTHECIN; CISPLATIN; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PACLITAXEL; PLEURAL EFFUSION, MALIGNANT; TAXOIDS;

EID: 23344453599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65: 55-63, 1983.
2. Fruehauf JP, Myers CE and Sinha BK: Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines. J Natl Cancer Inst 82: 1206-1209, 1990.
3. Salmon S, Mamburger A and Soehnlen B: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321-1327, 1978.
4. Tanigawa N, Kern DH, Hisaka Y and Morton DL: Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 42: 2159-2164, 1982.
5. Kern DH, Dogemullar CR, Kennedy MC, Hildebrand SL, Tanigawa N and Sondak VK: Development of miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 45: 5436-5441, 1985.
6. Kondo T, Imamura T and Ichihashi H: In vitro test for sensitivity of tumor to carcinostatic agents. Jpn J Cancer Res 57: 113-121, 1966.
7. Ohie S, Udagawa Y, Kozu A, Aoki D and Nozawa S: Cisplatin sensitivity of ovarian cancer in the histoculuture drug response assay correlates to clinical response to combination chemo-therapy with cisplatin, doxorubicin and cyclophosphamide. Anticancer Res 20: 2049-2054, 2000.
8. Kobayashi H: Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Rec Results Cancer Res 161: 48-61, 2003.
9. Araki Y, Isomoto H, Matsumoto A, Kaibara A, Yasunaga M, Hayashi K, Yatsugi H and Yamauchi K: An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures. Kurume Med J 46: 163-166, 1999.
10. Tamura Y, Kobayashi H, Taguchi T, Motoyama K, Inaji H and Noguchi S: Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. Int J Cancer 98: 450-455, 2002.
11. Yabushita H, Ohnishi M, Komiyama M, Mori T, Noguchi M, Kishida T, Noguchi Y, Sawaguchi K and Noguchi M: Usefulness of collagen gel droplet embedded culuture drug sensitivity testing in ovarian cancer. Oncol Rep 12: 307-311, 2003.
12. Vrscaj MU and Rakar S: Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study. Eur J Gynaecol Oncol 23: 405-410, 2002.